SGLT2 inhibitors for the treatment of type 2 diabetes


Project Status:
Project Line:
Health Technology Review
Project Sub Line:
Technology Review
Project Number:
Expected finish date:

The class of sodium-glucose cotransporter 2 (SGLT2) inhibitors is an integral part of the management of type 2 diabetes. This review will assess the evidence regarding the clinical effectiveness and harms of SGLT2 inhibitors compared to other glucose lowering drugs in adults with type 2 diabetes. The focus of the report will be on summarizing and appraising recent (from 2020 to present) systematic reviews with meta-analyses.

Reason: This project was turned into a Streamlined Review (TS002), which has now been completed.